Thermo Fisher Scientific Inc. (0R0H.L) LSE

Currency In USD

AD

Valuation

Market Cap219.4B
Enterprise Value250.4B
P/E Ratio25.47
PEG Ratio3.89
Price/Sales Ratio3.82
Price/Book Ratio3.32
Enterprise/Revenue4.7
Enterprise/EBITDA19.03

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.15
Operating Margin0.18
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.13

Income Statement

Revenue44.56B
Revenue/Share121.5
Gross Profit16.78B
EBITDA11.51B
Net Income6.74B
Diluted EPS17.74

Balance Sheet

Total Cash3.26B
Total Cash/Share8.75
Total Debt43.16B
Total Debt/Equity0.83
Current Ratio1.53
Book Value Per Share139.62

Price History

52-Week Change18.99
52-Week High603.14
52-Week Low416.66
Moving Average 50 Days556.84
Moving Average 200 Days522.32

Statistics

Average Volume13,249
Shares Outstanding371.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.8
Trailing Annual Dividend Yield0.39
Payout Ratio0.09
Last Split FactorN/A
Last Split DateN/A
AD